Targeting FGFR2 May Prevent or Delay Some KRAS-mutated Pancreatic Cancers
The preclinical study has implications for pancreatic cancer interception efforts PHILADELPHIA – Precancerous pancreatic lesions and some pancreatic ductal...
Search/Filter
Loading...
Keith T. Flaherty, MD, FAACR, Elected as American Association for Cancer Research President-Elect for 2025-2026
New Treasurer and five new Board of Directors members elected PHILADELPHIA – The members of the American Association for...
Douglas Hanahan, PhD, FAACR, Honored with the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research
CHICAGO – The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will...
AACR Announces Fellows of the AACR Academy Class of 2025 and New AACR Academy President
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected 2025 class of Fellows of...
Certain Genetic Alterations May Contribute to the Primary Resistance of Colorectal and Pancreatic Cancers to KRAS G12C Inhibitors
PHILADELPHIA – Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations...
AACR to Send 18 Early-career Researchers to Capitol Hill
WASHINGTON, D.C. – The American Association for Cancer Research (AACR) will host the tenth annual AACR Early-career Hill Day...
AACR Names Dr. Timothy Yap as Editor-in-Chief of the Journal Clinical Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Timothy A. Yap, MBBS, PhD, as...
AACR Statement and Call to Action Regarding the Administration’s Recent Actions Affecting NIH and the American People
The American Association for Cancer Research (AACR) is deeply concerned that the Administration’s recent actions are threatening the National...
Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer
PHILADELPHIA – Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab...
Dr. Daniel Nomura Selected as Editor-in-Chief of the AACR Journal Molecular Cancer Therapeutics
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Daniel K. Nomura, PhD, as editor-in-chief...